Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for prevention of cardiac surgery-associated AKI in intermediate-risk patients
ChiCTR2000034950Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levosimendan in acute kidney failure (AKF) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: RRT usage rate. Started Jul 2020; status: recruiting.
02
Drugs
levosimendan
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2000034950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034950.